177 related articles for article (PubMed ID: 26985241)
21. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps.
Agrawala RK; Choudhury AK; Mohanty BK; Baliarsinha AK
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):989-91. PubMed ID: 24825083
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of Berardinelli-Seip Congenital Lipodystrophy in Rio Grande do Norte State, Northeast Brazil.
de Azevedo Medeiros LB; Cândido Dantas VK; Craveiro Sarmento AS; Agnez-Lima LF; Meireles AL; Xavier Nobre TT; de Lima JG; de Melo Campos JTA
Diabetol Metab Syndr; 2017; 9():80. PubMed ID: 29046728
[TBL] [Abstract][Full Text] [Related]
23. Dental and periodontal alterations in Berardinelli-Seip syndrome.
Lima DL; Montenegro Júnior RM; Fernandes VO; Barros AI; Rêgo DM
J Int Acad Periodontol; 2007 Apr; 9(2):63-7. PubMed ID: 17506386
[TBL] [Abstract][Full Text] [Related]
24. Retinopathy and Uveitis in Congenital Generalized Lipodystrophy with Hypertriglyceridemia and Uncontrolled Diabetes (Berardinelli-Seip Syndrome).
Rubaie KA; Raef H; Stone DU; Kozak I
Middle East Afr J Ophthalmol; 2019; 26(4):250-252. PubMed ID: 32153340
[TBL] [Abstract][Full Text] [Related]
25. A case of Berardinelli-Seip syndrome presenting with cirrhosis.
Wimalaratna H; Nandasiri AS
J R Coll Physicians Edinb; 2013; 43(4):309-11. PubMed ID: 24350312
[TBL] [Abstract][Full Text] [Related]
26. Berardinelli-Seip congenital lipodystrophy.
Mandal K; Aneja S; Seth A; Khan A
Indian Pediatr; 2006 May; 43(5):440-5. PubMed ID: 16735770
[TBL] [Abstract][Full Text] [Related]
27. AGPAT2 gene mutation in a child with Berardinelli-Seip congenital lipodystrophy syndrome.
Rostami P; Nakhaeimoghadam M; Bijani FM; Sotoudeh A; Rabbani A; Hilbert P; Rezaei N
Ann Endocrinol (Paris); 2013 Feb; 74(1):59-61. PubMed ID: 23337016
[TBL] [Abstract][Full Text] [Related]
28. Severe cardiac phenotype of Berardinelli-Seip congenital lipodystrophy in an infant with homozygous E189X BSCL2 mutation.
Friguls B; Coroleu W; del Alcazar R; Hilbert P; Van Maldergem L; Pintos-Morell G
Eur J Med Genet; 2009; 52(1):14-6. PubMed ID: 19041432
[TBL] [Abstract][Full Text] [Related]
29. Berardinelli-Seip lipodystrophy.
Kobashi Y; Schoenbaum A; Hasserjian RP; Rosenthal DI
Skeletal Radiol; 2007 Oct; 36(10):999-1003. PubMed ID: 17554536
[TBL] [Abstract][Full Text] [Related]
30. Berardinelli-Seip Congenital Lipodystrophy Discovered Following a STEMI Event.
Beires F; Greenfield H; Brito da Silva J; Gil J; Moreno N
Eur J Case Rep Intern Med; 2022; 9(12):003658. PubMed ID: 36632537
[TBL] [Abstract][Full Text] [Related]
31. Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy.
Lima JG; Nobrega LHC; Lima NN; Dos Santos MCF; Silva PHD; Baracho MFP; Lima DN; de Melo Campos JTA; Ferreira LC; Freire Neto FP; Mendes-Aguiar CO; Jeronimo SMB
PLoS One; 2018; 13(6):e0199052. PubMed ID: 29883474
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity for congenital generalized lipodystrophy in seventeen patients from Oman.
Rajab A; Heathcote K; Joshi S; Jeffery S; Patton M
Am J Med Genet; 2002 Jul; 110(3):219-25. PubMed ID: 12116229
[TBL] [Abstract][Full Text] [Related]
33. Case report: Dental management of Berardinelli-Seip congenital lipodystrophy.
Bhujel N; Clark H
Eur Arch Paediatr Dent; 2016 Apr; 17(2):137-40. PubMed ID: 26573975
[TBL] [Abstract][Full Text] [Related]
34. Berardinelli Seip syndrome with insulin-resistant diabetes mellitus and stroke in an infant.
Indumathi CK; Lewin S; Ayyar V
Indian J Endocrinol Metab; 2011 Jul; 15(Suppl 1):S62-4. PubMed ID: 21847459
[TBL] [Abstract][Full Text] [Related]
35. Is it possible to achieve an acceptable disease control by dietary therapy alone in Berardinelli Seip type 1? Experience from a case report.
Cecchetti C; Belardinelli E; Dionese P; Teglia R; Fazzeri R; D' Apice MR; Vestito A; Pagotto U; Gambineri A
Front Endocrinol (Lausanne); 2023; 14():1190363. PubMed ID: 37347108
[TBL] [Abstract][Full Text] [Related]
36. Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases.
Vatier C; Vantyghem MC; Storey C; Jéru I; Christin-Maitre S; Fève B; Lascols O; Beltrand J; Carel JC; Vigouroux C; Bismuth E
Curr Med Res Opin; 2019 Mar; 35(3):543-552. PubMed ID: 30296183
[TBL] [Abstract][Full Text] [Related]
37. Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome.
Miranda DM; Wajchenberg BL; Calsolari MR; Aguiar MJ; Silva JM; Ribeiro MG; Fonseca C; Amaral D; Boson WL; Resende BA; De Marco L
Clin Endocrinol (Oxf); 2009 Oct; 71(4):512-7. PubMed ID: 19226263
[TBL] [Abstract][Full Text] [Related]
38. Congenital Generalized Lipoatrophy (Berardinelli-Seip Syndrome) Type 1: Description of Novel
Ceccarini G; Magno S; Pelosini C; Ferrari F; Sessa MR; Scabia G; Maffei M; Jéru I; Lascols O; Vigouroux C; Santini F
Front Endocrinol (Lausanne); 2020; 11():39. PubMed ID: 32117065
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the seipin and AGPAT2 genes clustering in consanguineous families with Berardinelli-Seip congenital lipodystrophy from two separate geographical regions of Brazil.
Gomes KB; Fernandes AP; Ferreira AC; Pardini H; Garg A; Magré J; Pardini VC
J Clin Endocrinol Metab; 2004 Jan; 89(1):357-61. PubMed ID: 14715872
[TBL] [Abstract][Full Text] [Related]
40. [Genetic and metabolic description of five patients with Berardinelli-Seip syndrome].
Barra CB; Savoldelli RD; Manna TD; Kim CA; Magre J; Porta G; Setian N; Damiani D
Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):54-9. PubMed ID: 21468520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
